Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805150 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently
A NA study of Myopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 4
- Study locations
NCT05805150: Completed NA study of Myopia, sponsored by CooperVision.
NCT05805150 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 69 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805150, a NA study of Myopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.
Primary Outcome
Ease of lens removal on a 0-100 scale (0= very difficult, 100= very easy)
Conditions Studied
Interventions
- DEVICE Control Lens (stenfilcon A)
- DEVICE Test Lens (senofilcon A)
Study Locations (4)
Kansas
- Kannarr Eye Care - Pittsburg
Minnesota
- Complete Eye Care of Medina - Medina
Pennsylvania
- Nittany Eye Associates - State College
Rhode Island
- West Bay Eye Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
What the finished NCT05805150 record still lists
NCT05805150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Control Lens (stenfilcon A) is the first listed.
NCT05805150 reports a single indexed study location in Kansas, Minnesota, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05805150 about?
NCT05805150 is a clinical study titled "Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently". The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.
What is the current status of trial NCT05805150?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2023-03-13. Estimated completion is 2023-06-01.
What conditions does trial NCT05805150 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05805150?
The interventions under investigation include: Control Lens (stenfilcon A) (DEVICE), Test Lens (senofilcon A) (DEVICE).
Who is sponsoring clinical trial NCT05805150?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805150 being conducted?
This trial has 4 study locations across Kansas, Minnesota, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05805150's enrollment target sits among peer trials
69 52nd of 90 higher than 39 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI